Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Orthopediatrics Corp(KIDS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for KIDS
09/25/2026: KIDS (2-star) is currently NOT-A-BUY. Pass it for now.
OrthoPediatrics Corp. is a specialized medical device company focused entirely on the pediatric orthopedic market, offering a broad range of implants and surgical systems. Its main strength lies in its niche focus and a dedicated sales force that creates strong relationships with pediatric surgeons. The company's primary growth opportunity is the continued penetration of international markets and the integration of advanced technologies, such as non-fusion spinal systems. Key risks include intense competition from larger medical device incumbents, high operational costs, and potential changes in healthcare reimbursement. It best suits growth investors who are willing to accept volatility in exchange for potential long-term, market-focused growth.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company targets a high-growth niche market with significant expansion potential. |
| Momentum investor | Mixed fit | This style is conditional on positive price trends and sustained revenue momentum. |
| Value investor | Weak fit | The company typically trades at high valuations relative to current earnings. |
| Dividend investor | Weak fit | The company does not pay a dividend and focuses capital on growth. |
| Low-risk investor | Weak fit | High volatility and operational risks make this unsuitable for low-risk profiles. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock often experiences significant price swings based on growth expectations. |
| Valuation risk | Medium / high | High price-to-sales ratios require consistent long-term growth to justify current prices. |
| Competition risk (Diversified MedTech) | Medium | Large incumbents could prioritize pediatric lines if the market becomes more attractive. |
| Business quality | Medium | The company has a strong niche franchise but is still scaling toward consistent profitability. |
| Dividend income | Low / none | Investors should not expect income from this equity. |
| Execution risk | Medium | Successfully integrating acquisitions and maintaining sales momentum is critical. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -36.96% | Avg. Invested days 34 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/25/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 588.78M USD | Price to earnings Ratio - | 1Y Target Price 27.22 |
Price to earnings Ratio - | 1Y Target Price 27.22 | ||
Volume (30-day avg) 215.8K shares | Beta 0.98 | 52 Weeks Range 14.42 - 26.74 | Updated Date 09/26/2026 |
52 Weeks Range 14.42 - 26.74 | Updated Date 09/26/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.68 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Trauma & Deformity | Plates, screws, and nails for pediatric fractures. | This is the core revenue driver for daily pediatric orthopedic surgical needs. |
| Scoliosis | Spinal fusion and non-fusion systems. | High-complexity implants for pediatric spinal conditions. |
| Geography | Primarily US-based with growing international operations. | The US remains the primary market for revenue. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE - | Enterprise Value 637.56M | Price to Sales(TTM) 2.33 |
Enterprise Value 637.56M | Price to Sales(TTM) 2.33 | ||
Enterprise Value to Revenue 2.52 | Enterprise Value to EBITDA 48.54 | Shares Outstanding 26.11M | Shares Floating 18.22M |
Shares Outstanding 26.11M | Shares Floating 18.22M | ||
Percent Insiders 29.7 | Percent Institutions 65.89 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Orthopediatrics Corp
Exchange NASDAQ | Headquarters Warsaw, IN, United States | ||
IPO Launch date 2017-10-12 | President, CEO & Director Mr. David R. Bailey | ||
Sector Healthcare | Industry Medical Devices | Full time employees 602 | Website https://www.orthopediatrics.com |
Full time employees 602 | Website https://www.orthopediatrics.com | ||
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.